Welcome to LookChem.com Sign In|Join Free
  • or
Acetamide, N-[4-[[6-[2-amino-4-(trifluoromethyl)phenyl]-4-pyrimidinyl]oxy]-2-benzothi azolyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

659731-60-9

Post Buying Request

659731-60-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

659731-60-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 659731-60-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,5,9,7,3 and 1 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 659731-60:
(8*6)+(7*5)+(6*9)+(5*7)+(4*3)+(3*1)+(2*6)+(1*0)=199
199 % 10 = 9
So 659731-60-9 is a valid CAS Registry Number.

659731-60-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-(6-(2-amino-4-(trifluoromethyl)phenyl)pyrimidin-4-yloxy)-benzo[d]thiazol-2-yl)acetamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:659731-60-9 SDS

659731-60-9Upstream product

659731-60-9Relevant academic research and scientific papers

Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists

Tamayo, Nuria,Liao, Hongyu,Stec, Markian M.,Wang, Xianghong,Chakrabarti, Partha,Retz, Dan,Doherty, Elizabeth M.,Surapaneni, Sekhar,Tamir, Rami,Bannon, Anthony W.,Gavva, Narender R.,Norman, Mark H.

, p. 2744 - 2757 (2008/12/22)

Transient receptor potential vanilloid 1 (TRPV1) channel antagonists may have clinical utility for the treatment of chronic nociceptive and neuropathic pain. We recently advanced a TRPV1 antagonist, 3 (AMG 517), into clinical trials as a new therapy for t

Substituted aryl pyrimidines as potent and soluble TRPV1 antagonists

Stec, Markian M.,Bo, Yunxin,Chakrabarti, Partha P.,Liao, Lillian,Ncube, Mqhele,Tamayo, Nuria,Tamir, Rami,Gavva, Narender R.,Treanor, James J.S.,Norman, Mark H.

scheme or table, p. 5118 - 5122 (2009/05/07)

Clinical candidate AMG 517 (1) is a potent antagonist toward multiple modes of activation of TRPV1; however, it suffers from poor solubility. Analogs with various substituents at the R region of 3 were prepared to improve the solubility while maintaining

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 659731-60-9